Abstract
Benefit proven only small lesions Additional visual loss after coagulation of subfoveal/juxtafoveal CNV Recurrence rate-50% within two years Most lesions are occult and are not laser eligible.
© 1999 Optical Society of America
PDF ArticleMore Like This
Sergey E. Avetisov, Maria V. Budzinskaja, Tatyana N Kiseleva, Natalia V. Balatskaya., Irina V. Gurova., Victor B. Loschenov, Sergey A. Shevchik, Sergey G. Kuzmin, and Georgy N. Vorozhtsov
6632_63 European Conference on Biomedical Optics (ECBO) 2007
I. Barbazetto
CThI1 The European Conference on Lasers and Electro-Optics (CLEO/Europe) 2000
Vera G. Likhvantseva, Ekaterina V. Osipova, Mikhail V. Petrenko, Oksana Yu. Merzlyakova, Sergey G. Kuzmin, and Georgy N. Vorozhtsov
6632_65 European Conference on Biomedical Optics (ECBO) 2007